Search results
Decoding Neurocrine Biosciences Inc (NBIX): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 20 hours agoNeurocrine Biosciences Inc showcases robust revenue growth and operational efficiency. Strategic...
Q1 2024 Neurocrine Biosciences Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 22 hours agoParticipants Eiry Wyn Roberts; Chief Medical Officer; Neurocrine Biosciences, Inc. Eric S. Benevich; Chief Commercial Officer;
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Position Trimmed by Intrust Bank NA
ETF DAILY NEWS· 19 hours agoIntrust Bank NA decreased its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 18.7% during the fourth quarter ...
Neurocrine Biosciences Inc (NBIX) Q1 2024 Earnings: Strong Revenue Growth and Strategic Advancements
GuruFocus.com via Yahoo Finance· 1 day agoOn May 1, 2024, Neurocrine Biosciences Inc (NASDAQ:NBIX) released its 8-K filing, unveiling the financial results for the first quarter ...
Neurocrine Biosciences Inc (NBIX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
GuruFocus.com via Yahoo Finance· 18 hours agoRelease Date: May 01, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Neurocrine Biosciences ...
US FDA approves Neurocrine Biosciences' movement disorder drug
Reuters· 14 hours ago, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on Tuesday. Huntington's disease is an inherited condition that causes the ...
Neurocrine Biosciences Announces U.S. FDA Approval of INGREZZA® SPRINKLE (valbenazine) Capsules
WKRN Nashville· 2 days agoNeurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the U.S. Food and Drug Administration has approved INGREZZA® SPRINKLE (valbenazine ...
Neurocrine: Q1 Earnings Snapshot
Midland Reporter-Telegram· 2 days agoSAN DIEGO (AP) — SAN DIEGO (AP) — Neurocrine Biosciences Inc. (NBIX) on Wednesday...
NBIX Stock Sees Surge of Approximately 3.94% in Last Five Days – Knox Daily
Knox Daily· 7 days agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Neurocrine Biosciences, < ...
abrdn plc Has $11.02 Million Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
ETF DAILY NEWS· 7 days agoThe firm owned 83,633 shares of the company’s stock after acquiring an additional 80,420 shares during the quarter. A number of other large investors have also made changes to their positions ...